Chair of the Australian Nuclear Science and Technology Organisation (ANSTO), Mr Jim McDowell, today confirmed that Dr Adi Paterson has been reappointed for five years as the Chief Executive Officer.
ANSTO is the home of Australia’s nuclear science expertise and is custodian of some of Australia’s most significant science and research infrastructure which benefits industry, people and the environment.
Dr Paterson commenced his tenure as CEO in March 2009, and under his leadership, for the past 7 years, the organisation has significantly expanded its national and international impact.
 |
Moving forward, Dr Paterson will continue to build on the major programs and projects that are helping drive ANSTO’s growth, including:
- The $168.8 million ANSTO Nuclear Medicine project which will come online in coming months and see ANSTO more than triple its production of potentially life-saving nuclear medicines;
- ANSTO’s assumption of operational control of the Australian Synchrotron, where since 2013 we have assisted in driving increased industry utilisation and secured 10 years operational funding;
- With the support of the Board and staff, improving the organisational culture of ANSTO and continuing ANSTO’s outward focused strategies; and
- Continuing to build, foster and reinforce ANSTO’s strong relationships with nuclear science, governmental, research, and global stakeholders.
Mr McDowell said that it is Dr Paterson’s leadership, achievements to date and strong vision for ANSTO’s future that have made the Board confident of Dr Paterson’s continued leadership.
“Dr Paterson has lead ANSTO exceptionally well, and will continue to do so. With Dr Paterson at the helm we are well positioned to continue to deliver strong outcomes for Australia,” said Mr McDowell.
Mr McDowell formally appointed Dr Paterson on Friday 29 April 2016, after endorsement by cabinet.
Media contact: Phil McCall 0438 619 987
Published: 09/05/2016